Earnings Call · Q4 FY2021·2022-02-16

Q4 21EPS -100.00%*·Rev n/aQ3 21EPS +28.57%·Rev n/aQ2 21EPS +52.17%·Rev n/aQ1 21EPS +42.11%·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Eric Jaschke — Head of Investor Relations

Serge Saxonov — Co-founder and CEO

Justin McAnear — Chief Financial Officer

−14.7%1d on move date−12.6% vs SPY3d−17.2%5d−18.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access